In this cohort study, we aimed to delineate the role of vinorelbine as a replacement for vincristine in R-CHOP after onset of peripheral neuropathy in the treatment of de novo DLBCL. The gene discussed is DDIT3; the disease is diffuse large B-cell lymphoma.